USTR Says Stance On Drug Patents 'Flexible' In TPP Talks
The U.S. Trade Representative's office said Wednesday it will seek a "flexible" approach to pharmaceutical intellectual property provisions in the Trans-Pacific Partnership, attempting to allow access to lifesaving medicine while also...To view the full article, register now.
Already a subscriber? Click here to view full article